-1%
Glyset Vita SC Injection is a rapid-acting insulin analogue indicated for improving glycemic control in patients with diabetes mellitus.
Glyset Vita is a sterile, clear solution of human insulin analogue (Insulin Aspart) intended for subcutaneous injection or infusion, as well as intravenous administration under medical supervision. It is a fast-acting blood glucose–lowering agent with a quicker onset of action compared to soluble human insulin.
Structurally, Insulin Aspart differs from regular human insulin by a single amino acid substitution—aspartic acid replacing proline at position B28—which accounts for its rapid absorption. It is produced using recombinant DNA technology.
Insulin Aspart primarily regulates glucose metabolism by binding to insulin receptors on muscle and adipose tissue. This promotes cellular glucose uptake while simultaneously suppressing hepatic glucose production, resulting in effective lowering of blood glucose levels.